Literature DB >> 28619417

Point-of-Care Testing for Anemia, Diabetes, and Hypertension: A Pharmacy-Based Model in Lima, Peru.

Enrique M Saldarriaga1, Elisabeth Vodicka2, Sayda La Rosa1, Maria Valderrama1, Patricia J Garcia3.   

Abstract

BACKGROUND: Prevention and control of chronic diseases is a high priority for many low- and middle-income countries. This study evaluated the feasibility and acceptability of training pharmacy workers to provide point-of-care testing for 3 chronic diseases-hypertension, diabetes, and anemia-to improve disease detection and awareness through private pharmacies.
METHODS: We developed a multiphase training curriculum for pharmacists and pharmacy technicians to build capacity for identification of risk factors, patient education, point-of-care testing, and referral for abnormal results. We conducted a pre-post evaluation with participants and evaluated results using Student t test for proportions. We conducted point-of-care testing with pharmacy clients and evaluated acceptability by patient characteristics (age, gender, and type of patient) using multiple logistic regression.
RESULTS: In total, 72 pharmacy workers (66%) completed the full training curriculum. Pretest scores indicated that pharmacists had more knowledge and skills in chronic disease risk factors, patient education, and testing than pharmacy technicians. All participants improved their knowledge and skills after the training, and post-test scores indicated that pharmacy technicians achieved the same level of competency as pharmacists (P < .01). Additionally, 698 clients received at least 1 test during the study; 53% completed the acceptability survey. Nearly 100% thought the pharmacy could provide faster results, faster and better attention, and better access to basic screening for hypertension, diabetes, and anemia than a traditional health center. Fast service was very important: 41% ranked faster results and 30% ranked faster attention as the most important factor for receiving diagnostic testing in the pharmacy. DISCUSSION: We found that it is both feasible for pharmacies and acceptable to clients to train pharmacy workers to provide point-of-care testing for anemia, diabetes, and hypertension. This innovative approach holds potential to increase early detection of risk factors and bolster disease prevention and management efforts in Peru and other low- and middle-income settings.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  POC test; Peru; anemia; diabetes; hypertension; pharmacies; point-of-care testing; rapid test

Mesh:

Year:  2017        PMID: 28619417     DOI: 10.1016/j.aogh.2017.03.514

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  5 in total

1.  Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey.

Authors:  Janelle Patel; Nikki Christofferson; Kellie J Goodlet
Journal:  J Am Pharm Assoc (2003)       Date:  2021-08-19

2.  Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.

Authors:  Anthony T Saxton; J Jaime Miranda; Ernesto J Ortiz; William Pan
Journal:  Ann Glob Health       Date:  2018-11-05       Impact factor: 2.462

3.  Evaluation of the Community Pharmacy Comorbidities Screening Service on Patients with Chronic Diseases.

Authors:  Jędrzej Lewicki; Urszula Religioni; Piotr Merks
Journal:  Patient Prefer Adherence       Date:  2021-07-17       Impact factor: 2.711

4.  Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru.

Authors:  Patricia J García; Gustavo Hernández-Córdova; Paria Pourjavaheri; Hilbert J Gómez-Paredes; Samuel Sudar; Angela M Bayer
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

5.  Patients' and healthcare providers' perspectives of diabetes management in Cambodia: a qualitative study.

Authors:  Ei Ei Khaing Nang; Chhavarath Dary; Li Yang Hsu; Sokrath Sor; Vonthanak Saphonn; Konstantin Evdokimov
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.